Keith S. Kaye, MD

Rutgers University

Disclosure(s): GSK: Advisor/Consultant; merck: Advisor/Consultant, Stocks/Bonds; Qpex: Advisor/Consultant; Shionogi: Advisor/Consultant; Spero: Advisor/Consultant

Poster(s):

• 424 - Risk Factors for Infection or Colonization with Piperacillin-tazobactam (TZP) Resistant P. aeruginosa (PSA) with Increasing Degrees of β-lactam Resistance
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET